A case study explored three pediatric patients who developed paradoxic eczema after receiving cardiac transplantation in infancy on a systemic antirejection therapy.
In the patients, the drug, tacrolimus, used to treat eczema, was linked to severe dermatitis in a subset of solid organ transplant recipients.
Clinicians who manage children requiring anti-rejection therapy should be aware of the possible drug-associated adverse effect of tacrolimus.
Learn more about this link at the Journal of the American Academy of Dermatology.